Posted inStock Dow futures slip 214 points amid Fed jitters: 5 things to know before Wall Street opens Dow futures were under pressure on Friday, falling about 214 points, roughly 0.5% as investors… November 14, 2025 Posted inStock How Caterpillar is emerging as an AI giant: Wells Fargo Caterpillar shares may still have room to climb, according to Wells Fargo, which initiated coverage… November 14, 2025 Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock How Caterpillar is emerging as an AI giant: Wells Fargo Caterpillar shares may still have room to climb, according to Wells Fargo, which initiated coverage… November 14, 2025 Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock SoFi plans crypto comeback within 6 months, says CEO Anthony Noto SoFi Technologies Inc (NASDAQ: SOFI) chief executive Anthony Noto says the neobank is fully committed… April 30, 2025
Posted inStock Asian stock close mixed: Nikkei jumps 0.5%, CSI 300, Nifty end flat Asian equities closed mixed on Wednesday, weighed by weak regional factory data, cautious corporate guidance… April 30, 2025
Posted inStock How Warren Buffett plays US stocks during uncertain times US stocks remain volatile as investors wait and see how the tariff situation unravels moving… April 30, 2025
Posted inStock Starbucks (SBUX) stock dips on Q2 miss: analysts warn of slow recovery, tariff risks After prolonged struggles with declining sales and fading customer loyalty, Starbucks is on a mission… April 30, 2025
Posted inStock Long FMAO: FMAO Breaks Key Resistance on Strong Q1 Earnings, Bullish Momentum Ahead April 30, 2025
Posted inStock CEO explains why IonQ is ‘most efficient and wisest’ among quantum companies IonQ Inc (NASDAQ: IONQ) chief executive Niccolo De Masi says the Chinese government is spending… April 30, 2025
Posted inStock Waymo’s potential: how big of an opportunity is it for Google? Waymo continues to commercialise its robotaxi operations across the US. In fact, nationwide, it’s now… April 30, 2025
Posted inStock US stocks open in the red: Dow slips 1.5%, Nasdaq slips over 2% The post US stocks open in the red: Dow slips 1.5%, Nasdaq slips over 2%… April 30, 2025
Posted inPolitics Houston Rockets owner among trio of Trump ambassador nominees confirmed by Senate A prominent NBA team owner was among three of President Donald Trump’s diplomatic nominees confirmed… April 30, 2025
Posted inPolitics DOGE terminates billions in contracts, including $361K for ‘gender non-conforming, non-binary’ BIPOC farmers The Department of Agriculture (USDA) terminad $2.5 billion in ‘wasteful’ grants that went toward gender-based… April 30, 2025